CliffBio
small molecule

GILENYA

FINGOLIMOD HYDROCHLORIDE

Loss of exclusivitySeptember 2032latest FDA-listed patent expiry
CompanyNovartis →See this company's full patent-cliff portfolio

Drug detail

Brand nameGILENYA
Active ingredientFINGOLIMOD HYDROCHLORIDE
StrengthEQ 0.25MG BASE
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalMay 2018
Marketing statusRX

Listed patents

PatentExpiresType
9592208*PEDSeptember 2032—
9592208March 2032product

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.